Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2017 1
2018 1
2019 2
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all The following term was ignored: :
Page 1
Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases.
Ciszewski A. Ciszewski A. Vaccine. 2018 Jan 4;36(2):202-206. doi: 10.1016/j.vaccine.2017.11.078. Epub 2017 Dec 6. Vaccine. 2018. PMID: 29221893 Review.
Due to the wide interaction between the respiratory and the circulatory systems, influenza and pneumococcal vaccinations are recommended in the prevention and treatment of cardiovascular diseases. The review summarizes the results of recent studies and meta-a …
Due to the wide interaction between the respiratory and the circulatory systems, influenza and pneumococcal vaccinations are r …
Effect of Influenza on Outcomes in Patients With Heart Failure.
Panhwar MS, Kalra A, Gupta T, Kolte D, Khera S, Bhatt DL, Ginwalla M. Panhwar MS, et al. JACC Heart Fail. 2019 Feb;7(2):112-117. doi: 10.1016/j.jchf.2018.10.011. Epub 2019 Jan 2. JACC Heart Fail. 2019. PMID: 30611718 Free article. Clinical Trial.
BACKGROUND: Patients with HF may be at increased risk of morbidity and mortality from influenza infection. However, there are limited data for the associated hazards of influenza infection in patients with HF. ...CONCLUSIONS: Influenza
BACKGROUND: Patients with HF may be at increased risk of morbidity and mortality from influenza infection. However, the …
Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design.
Loeb M, Dokainish H, Dans A, Palileo-Villanueva LM, Roy A, Karaye K, Zhu J, Liang Y, Goma F, Damasceno A, AlHabib KF, Yonga G, Mondo C, Almahmeed W, Al Mulla A, Yusuf S; IVVE investigators. Loeb M, et al. Am Heart J. 2019 Jun;212:36-44. doi: 10.1016/j.ahj.2019.02.009. Epub 2019 Mar 11. Am Heart J. 2019. PMID: 30933856 Free PMC article. Clinical Trial.
BACKGROUND: Influenza is associated with an increase in the risk of cardiac and other vascular events. Observational data and small randomized trials suggest that influenza vaccination may reduce such adverse vascular events. ...CONCLUSION: This …
BACKGROUND: Influenza is associated with an increase in the risk of cardiac and other vascular events. Observational da …
Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.
Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP. Udell JA, et al. JAMA. 2013 Oct 23;310(16):1711-20. doi: 10.1001/jama.2013.279206. JAMA. 2013. PMID: 24150467
OBJECTIVES: To determine if influenza vaccination is associated with prevention of cardiovascular events. DATA SOURCES AND STUDY SELECTION: A systematic review and meta-analysis of MEDLINE (1946-August 2013), EMBASE (1947-August 2013), and the Cochrane …
OBJECTIVES: To determine if influenza vaccination is associated with prevention of cardiovascular events. DATA S …
Influenza vaccination and major adverse vascular events in high-risk patients.
Johnstone J, Loeb M, Teo KK, Gao P, Dyal L, Liu L, Avezum A, Cardona-Munoz E, Sleight P, Fagard R, Yusuf S; Ongoing Telmisartan Alone and in Combination With Ramipril Global EndPoint Trial (ONTARGET); Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease (TRANSCEND) Investigators. Johnstone J, et al. Circulation. 2012 Jul 17;126(3):278-86. doi: 10.1161/CIRCULATIONAHA.111.071100. Epub 2012 Jun 19. Circulation. 2012. PMID: 22715472
In 2003 to 2004, there was an incomplete match between circulating influenza and the vaccine antigen, and there was no association between influenza vaccination and the outcome (adjusted OR, 0.96; 95% CI, 0.73-1.27). ...The reduction in …
In 2003 to 2004, there was an incomplete match between circulating influenza and the vaccine antigen, and there was no asso
The burden of influenza complications in different high-risk groups: a targeted literature review.
Mauskopf J, Klesse M, Lee S, Herrera-Taracena G. Mauskopf J, et al. J Med Econ. 2013;16(2):264-77. doi: 10.3111/13696998.2012.752376. Epub 2012 Dec 4. J Med Econ. 2013. PMID: 23173567 Review.
A limitation of the review is that most of the studies of hospitalized patients did not present outcomes data separately by high-risk group and only limited data were identified on rates of hospitalization or lower respiratory tract infection for most …
A limitation of the review is that most of the studies of hospitalized patients did not present outcomes data separately by …
Changes in Preventative Health Care After Medicaid Expansion.
Tummalapalli SL, Keyhani S. Tummalapalli SL, et al. Med Care. 2020 Jun;58(6):549-556. doi: 10.1097/MLR.0000000000001307. Med Care. 2020. PMID: 32028524
Our primary outcomes were preventative health care services, which we categorized as cancer screening (breast cancer, cervical cancer, and colorectal cancer); cardiovascular risk reduction (serum cholesterol screening in low-risk groups, serum choleste …
Our primary outcomes were preventative health care services, which we categorized as cancer screening (breast cancer, cervical cancer …
Seasonality of postoperative pneumonia after coronary artery bypass grafting: A national inpatient sample study.
Martin TJ, Eltorai AEM, Kennedy K, Sellke F, Ehsan A. Martin TJ, et al. J Card Surg. 2020 Jun;35(6):1258-1266. doi: 10.1111/jocs.14577. Epub 2020 Apr 27. J Card Surg. 2020. PMID: 32340078
A significantly increased risk of postoperative pneumonia (adjusted odds ratio [aOR] = 1.15) and infection with influenza (aOR = 4.08), Haemophilus influenzae (aOR = 1.40), and Streptococcus pneumoniae (aOR = 1.47) was observed among patients receiving …
A significantly increased risk of postoperative pneumonia (adjusted odds ratio [aOR] = 1.15) and infection with influenza (aOR …
Feedback